Baxter International | BAX - Ebitda


Baxter International reported $-447M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Abbott USD 3.27B 178M Dec/2025
AngioDynamics USD 5.94M 3.78M Sep/2025
Artivion USD 22.72M 1.84M Dec/2025
AtriCure USD 17.07M 2.79M Mar/2026
Avanos Medical USD 13M 3M Dec/2025
Baxter International USD -447M 873M Dec/2025
Becton, Dickinson and Co. USD 1.71B 433M Dec/2025
Boston Scientific USD 1.16B 213M Dec/2025
Cooper Companies USD 323.4M 13.2M Dec/2025
Dexcom USD 364.5M 57.7M Mar/2026
Edwards Lifesciences USD 70.1M 394.2M Dec/2025
Fresenius EUR 951M 283M Mar/2026
Globus Medical USD 280.46M 27.86M Dec/2025
Halozyme Therapeutics USD 219.57M 197.66M Mar/2026
ICU Medical USD 98.68M 489K Mar/2026
Insulet USD 181.7M 12.3M Mar/2026
Integra LifeSciences USD 76.18M 28.03M Mar/2026
Intuitive Surgical USD 1.09B 165.5M Dec/2025
J&J USD 7.19B 2.32B Dec/2025
Laboratory Of America USD 605.6M 17.5M Mar/2026
Masimo USD 85.5M 6.4M Mar/2026
Medtronic USD 2.81B 119M Mar/2026
Merit Medical Systems USD 97.23M 17.69M Dec/2025
Quest Diagnostics USD 557M 20M Mar/2026
Smith & Nephew USD 796M 139M Dec/2025
Stryker USD 1.57B 618M Mar/2026
Tandem Diabetes Care USD 2.73M 30.17M Mar/2026
Teleflex USD 247.07M 575.88M Dec/2025
Terumo JPY 57.88B 12.1B Mar/2026
Zimmer Biomet Holdings USD 759M 120.8M Dec/2025